Bone Density Reduction: Tenofovir has long been connected to a decrease in bone mineral density, increasing the potential risk of bone complications or fractures. Dolutegravir is undoubtedly an antiviral agent utilized for the treatment of HIV-1 infections in combination with other antiretroviral brokers. It is usually recommended that doses of https://hivhub.in/product/viropil-tablet/